TaTME and the worse oncological outcome - new data demonstrates a difficult method
- PMID: 32936942
- DOI: 10.1002/bjs.11850
TaTME and the worse oncological outcome - new data demonstrates a difficult method
Comment in
-
Author response to: TaTME and the worse oncological outcome - new data demonstrates a difficult method.Br J Surg. 2020 Nov;107(12):e612. doi: 10.1002/bjs.11849. Epub 2020 Sep 17. Br J Surg. 2020. PMID: 32940346 No abstract available.
Comment on
-
Locoregional recurrences after transanal total mesorectal excision of rectal cancer during implementation.Br J Surg. 2020 Aug;107(9):1211-1220. doi: 10.1002/bjs.11525. Epub 2020 Apr 4. Br J Surg. 2020. PMID: 32246472 Free PMC article.
References
-
- van Oostendorp SE, Belgers HJ, Bootsma BT, Hol JC, Belt EJTH, Bleeker W et al. Locoregional recurrences after transanal total mesorectal excision of rectal cancer during implementation. Br J Surg 2020; 107: 1211-1220.
-
- Wasmuth HH, Faerden AE, Myklebust TÅ, Pfeffer F, Norderval S, Riis R et al. Transanal total mesorectal excision for rectal cancer has been suspended in Norway. Br J Surg 2020; 107: 121-130.
-
- Chen YT, KIu KT, Yen MH, Chang TC. Compariison of short-term outcomes in lower rectal cancer using three different surgical techniques: Transanal total mesorectal exicion (TME), laparoscopic TME, and open TME. Asian J Surg 2019; 42: 674-680.
-
- Mege D, Hain E, Lakkis Z, Maggiori L, Prost À la Denise J, Panis Y. Is trans-anal total mesorectal excision really safe and better than laparoscopic total mesorectal excision with a perineal approach first in patients with low rectal cancer? A learning curve with case-matched study in 68 patients. Colorectal Dis 2018; 20: O143-O151.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
